nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Epirubicin—pancreatic cancer	0.0684	0.0866	CbGbCtD
Mifepristone—ABCC1—Irinotecan—pancreatic cancer	0.0666	0.0842	CbGbCtD
Mifepristone—ABCC1—Docetaxel—pancreatic cancer	0.0488	0.0617	CbGbCtD
Mifepristone—CYP3A7—Tamoxifen—pancreatic cancer	0.0429	0.0542	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0429	0.0542	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—pancreatic cancer	0.0364	0.046	CbGbCtD
Mifepristone—CYP3A7—Irinotecan—pancreatic cancer	0.0329	0.0416	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0329	0.0416	CbGbCtD
Mifepristone—CYP3A5—Tamoxifen—pancreatic cancer	0.0321	0.0407	CbGbCtD
Mifepristone—CYP3A5—Erlotinib—pancreatic cancer	0.0273	0.0346	CbGbCtD
Mifepristone—CYP3A5—Irinotecan—pancreatic cancer	0.0247	0.0312	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0241	0.0305	CbGbCtD
Mifepristone—CYP3A7—Docetaxel—pancreatic cancer	0.0241	0.0305	CbGbCtD
Mifepristone—CYP3A7—Sunitinib—pancreatic cancer	0.024	0.0304	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.024	0.0304	CbGbCtD
Mifepristone—ABCB1—Tamoxifen—pancreatic cancer	0.0209	0.0265	CbGbCtD
Mifepristone—CYP2D6—Tamoxifen—pancreatic cancer	0.0197	0.0249	CbGbCtD
Mifepristone—CYP3A5—Docetaxel—pancreatic cancer	0.0181	0.0229	CbGbCtD
Mifepristone—ABCB1—Gemcitabine—pancreatic cancer	0.018	0.0228	CbGbCtD
Mifepristone—CYP3A5—Sunitinib—pancreatic cancer	0.018	0.0228	CbGbCtD
Mifepristone—ABCB1—Erlotinib—pancreatic cancer	0.0178	0.0225	CbGbCtD
Mifepristone—CYP2D6—Erlotinib—pancreatic cancer	0.0168	0.0212	CbGbCtD
Mifepristone—ABCB1—Irinotecan—pancreatic cancer	0.0161	0.0203	CbGbCtD
Mifepristone—CYP3A4—Tamoxifen—pancreatic cancer	0.0125	0.0159	CbGbCtD
Mifepristone—ABCB1—Docetaxel—pancreatic cancer	0.0118	0.0149	CbGbCtD
Mifepristone—ABCB1—Sunitinib—pancreatic cancer	0.0117	0.0148	CbGbCtD
Mifepristone—CYP3A4—Erlotinib—pancreatic cancer	0.0107	0.0135	CbGbCtD
Mifepristone—CYP3A4—Irinotecan—pancreatic cancer	0.00963	0.0122	CbGbCtD
Mifepristone—ABCB1—Doxorubicin—pancreatic cancer	0.00878	0.0111	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—pancreatic cancer	0.00827	0.0105	CbGbCtD
Mifepristone—CYP3A4—Docetaxel—pancreatic cancer	0.00705	0.00893	CbGbCtD
Mifepristone—CYP3A4—Sunitinib—pancreatic cancer	0.00702	0.00888	CbGbCtD
Mifepristone—CYP3A4—Doxorubicin—pancreatic cancer	0.00526	0.00665	CbGbCtD
Mifepristone—Skin disorder—Gemcitabine—pancreatic cancer	0.0003	0.00186	CcSEcCtD
Mifepristone—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000298	0.00185	CcSEcCtD
Mifepristone—Hot flush—Doxorubicin—pancreatic cancer	0.000298	0.00185	CcSEcCtD
Mifepristone—Dizziness—Tamoxifen—pancreatic cancer	0.000297	0.00184	CcSEcCtD
Mifepristone—Hypotension—Irinotecan—pancreatic cancer	0.000296	0.00184	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000295	0.00183	CcSEcCtD
Mifepristone—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000295	0.00183	CcSEcCtD
Mifepristone—Anorexia—Gemcitabine—pancreatic cancer	0.000294	0.00183	CcSEcCtD
Mifepristone—Dizziness—Erlotinib—pancreatic cancer	0.000294	0.00182	CcSEcCtD
Mifepristone—Anorexia—Fluorouracil—pancreatic cancer	0.00029	0.0018	CcSEcCtD
Mifepristone—Hypotension—Gemcitabine—pancreatic cancer	0.000289	0.00179	CcSEcCtD
Mifepristone—Insomnia—Irinotecan—pancreatic cancer	0.000287	0.00178	CcSEcCtD
Mifepristone—Vomiting—Tamoxifen—pancreatic cancer	0.000286	0.00177	CcSEcCtD
Mifepristone—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000285	0.00177	CcSEcCtD
Mifepristone—Hypotension—Fluorouracil—pancreatic cancer	0.000284	0.00176	CcSEcCtD
Mifepristone—Hypersensitivity—Sunitinib—pancreatic cancer	0.000284	0.00176	CcSEcCtD
Mifepristone—Rash—Tamoxifen—pancreatic cancer	0.000283	0.00176	CcSEcCtD
Mifepristone—Dermatitis—Tamoxifen—pancreatic cancer	0.000283	0.00176	CcSEcCtD
Mifepristone—Vomiting—Erlotinib—pancreatic cancer	0.000283	0.00175	CcSEcCtD
Mifepristone—Dyspnoea—Irinotecan—pancreatic cancer	0.000283	0.00175	CcSEcCtD
Mifepristone—Somnolence—Irinotecan—pancreatic cancer	0.000282	0.00175	CcSEcCtD
Mifepristone—Headache—Tamoxifen—pancreatic cancer	0.000282	0.00175	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000281	0.00175	CcSEcCtD
Mifepristone—Rash—Erlotinib—pancreatic cancer	0.00028	0.00174	CcSEcCtD
Mifepristone—Dermatitis—Erlotinib—pancreatic cancer	0.00028	0.00174	CcSEcCtD
Mifepristone—Angiopathy—Docetaxel—pancreatic cancer	0.00028	0.00174	CcSEcCtD
Mifepristone—Insomnia—Gemcitabine—pancreatic cancer	0.000279	0.00173	CcSEcCtD
Mifepristone—Headache—Erlotinib—pancreatic cancer	0.000279	0.00173	CcSEcCtD
Mifepristone—Pain in extremity—Doxorubicin—pancreatic cancer	0.000278	0.00173	CcSEcCtD
Mifepristone—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000278	0.00172	CcSEcCtD
Mifepristone—Chills—Docetaxel—pancreatic cancer	0.000277	0.00172	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000277	0.00172	CcSEcCtD
Mifepristone—Asthenia—Sunitinib—pancreatic cancer	0.000276	0.00171	CcSEcCtD
Mifepristone—Decreased appetite—Irinotecan—pancreatic cancer	0.000276	0.00171	CcSEcCtD
Mifepristone—Dyspnoea—Gemcitabine—pancreatic cancer	0.000275	0.00171	CcSEcCtD
Mifepristone—Insomnia—Fluorouracil—pancreatic cancer	0.000275	0.0017	CcSEcCtD
Mifepristone—Somnolence—Gemcitabine—pancreatic cancer	0.000275	0.0017	CcSEcCtD
Mifepristone—Hypokalaemia—Epirubicin—pancreatic cancer	0.000274	0.0017	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000274	0.0017	CcSEcCtD
Mifepristone—Fatigue—Irinotecan—pancreatic cancer	0.000273	0.0017	CcSEcCtD
Mifepristone—Pruritus—Sunitinib—pancreatic cancer	0.000272	0.00169	CcSEcCtD
Mifepristone—Breast disorder—Epirubicin—pancreatic cancer	0.000272	0.00169	CcSEcCtD
Mifepristone—Pain—Irinotecan—pancreatic cancer	0.000271	0.00168	CcSEcCtD
Mifepristone—Constipation—Irinotecan—pancreatic cancer	0.000271	0.00168	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000271	0.00168	CcSEcCtD
Mifepristone—Dyspnoea—Fluorouracil—pancreatic cancer	0.000271	0.00168	CcSEcCtD
Mifepristone—Mental disorder—Docetaxel—pancreatic cancer	0.00027	0.00168	CcSEcCtD
Mifepristone—Somnolence—Fluorouracil—pancreatic cancer	0.00027	0.00167	CcSEcCtD
Mifepristone—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000269	0.00167	CcSEcCtD
Mifepristone—Malnutrition—Docetaxel—pancreatic cancer	0.000269	0.00167	CcSEcCtD
Mifepristone—Decreased appetite—Gemcitabine—pancreatic cancer	0.000269	0.00167	CcSEcCtD
Mifepristone—Nausea—Tamoxifen—pancreatic cancer	0.000267	0.00166	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000267	0.00165	CcSEcCtD
Mifepristone—Fatigue—Gemcitabine—pancreatic cancer	0.000266	0.00165	CcSEcCtD
Mifepristone—Muscular weakness—Epirubicin—pancreatic cancer	0.000265	0.00165	CcSEcCtD
Mifepristone—Pain—Gemcitabine—pancreatic cancer	0.000264	0.00164	CcSEcCtD
Mifepristone—Constipation—Gemcitabine—pancreatic cancer	0.000264	0.00164	CcSEcCtD
Mifepristone—Nausea—Erlotinib—pancreatic cancer	0.000264	0.00164	CcSEcCtD
Mifepristone—Decreased appetite—Fluorouracil—pancreatic cancer	0.000264	0.00164	CcSEcCtD
Mifepristone—Diarrhoea—Sunitinib—pancreatic cancer	0.000263	0.00163	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000262	0.00163	CcSEcCtD
Mifepristone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000261	0.00162	CcSEcCtD
Mifepristone—Back pain—Docetaxel—pancreatic cancer	0.00026	0.00161	CcSEcCtD
Mifepristone—Pain—Fluorouracil—pancreatic cancer	0.00026	0.00161	CcSEcCtD
Mifepristone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000259	0.00161	CcSEcCtD
Mifepristone—Muscle spasms—Docetaxel—pancreatic cancer	0.000258	0.0016	CcSEcCtD
Mifepristone—Dizziness—Sunitinib—pancreatic cancer	0.000255	0.00158	CcSEcCtD
Mifepristone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000255	0.00158	CcSEcCtD
Mifepristone—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000253	0.00157	CcSEcCtD
Mifepristone—Breast disorder—Doxorubicin—pancreatic cancer	0.000252	0.00156	CcSEcCtD
Mifepristone—Abdominal pain—Irinotecan—pancreatic cancer	0.000251	0.00155	CcSEcCtD
Mifepristone—Body temperature increased—Irinotecan—pancreatic cancer	0.000251	0.00155	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000251	0.00155	CcSEcCtD
Mifepristone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00025	0.00155	CcSEcCtD
Mifepristone—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000249	0.00154	CcSEcCtD
Mifepristone—Muscular weakness—Doxorubicin—pancreatic cancer	0.000246	0.00152	CcSEcCtD
Mifepristone—Vomiting—Sunitinib—pancreatic cancer	0.000245	0.00152	CcSEcCtD
Mifepristone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000244	0.00151	CcSEcCtD
Mifepristone—Rash—Sunitinib—pancreatic cancer	0.000243	0.00151	CcSEcCtD
Mifepristone—Dermatitis—Sunitinib—pancreatic cancer	0.000243	0.0015	CcSEcCtD
Mifepristone—Urticaria—Fluorouracil—pancreatic cancer	0.000241	0.0015	CcSEcCtD
Mifepristone—Headache—Sunitinib—pancreatic cancer	0.000241	0.0015	CcSEcCtD
Mifepristone—Body temperature increased—Fluorouracil—pancreatic cancer	0.00024	0.00149	CcSEcCtD
Mifepristone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000234	0.00145	CcSEcCtD
Mifepristone—Hypertension—Docetaxel—pancreatic cancer	0.000232	0.00144	CcSEcCtD
Mifepristone—Infestation NOS—Epirubicin—pancreatic cancer	0.000232	0.00144	CcSEcCtD
Mifepristone—Infestation—Epirubicin—pancreatic cancer	0.000232	0.00144	CcSEcCtD
Mifepristone—Myalgia—Docetaxel—pancreatic cancer	0.000229	0.00142	CcSEcCtD
Mifepristone—Arthralgia—Docetaxel—pancreatic cancer	0.000229	0.00142	CcSEcCtD
Mifepristone—Nausea—Sunitinib—pancreatic cancer	0.000229	0.00142	CcSEcCtD
Mifepristone—Asthenia—Irinotecan—pancreatic cancer	0.000228	0.00141	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000227	0.00141	CcSEcCtD
Mifepristone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000224	0.00139	CcSEcCtD
Mifepristone—Dry mouth—Docetaxel—pancreatic cancer	0.000224	0.00139	CcSEcCtD
Mifepristone—Asthenia—Gemcitabine—pancreatic cancer	0.000222	0.00137	CcSEcCtD
Mifepristone—Oedema—Docetaxel—pancreatic cancer	0.000219	0.00136	CcSEcCtD
Mifepristone—Pruritus—Gemcitabine—pancreatic cancer	0.000219	0.00136	CcSEcCtD
Mifepristone—Infection—Docetaxel—pancreatic cancer	0.000218	0.00135	CcSEcCtD
Mifepristone—Sinusitis—Epirubicin—pancreatic cancer	0.000218	0.00135	CcSEcCtD
Mifepristone—Diarrhoea—Irinotecan—pancreatic cancer	0.000217	0.00135	CcSEcCtD
Mifepristone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000215	0.00133	CcSEcCtD
Mifepristone—Pruritus—Fluorouracil—pancreatic cancer	0.000215	0.00133	CcSEcCtD
Mifepristone—Infestation NOS—Doxorubicin—pancreatic cancer	0.000215	0.00133	CcSEcCtD
Mifepristone—Infestation—Doxorubicin—pancreatic cancer	0.000215	0.00133	CcSEcCtD
Mifepristone—Skin disorder—Docetaxel—pancreatic cancer	0.000213	0.00132	CcSEcCtD
Mifepristone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000211	0.00131	CcSEcCtD
Mifepristone—Dizziness—Irinotecan—pancreatic cancer	0.00021	0.0013	CcSEcCtD
Mifepristone—Haemoglobin—Epirubicin—pancreatic cancer	0.000209	0.0013	CcSEcCtD
Mifepristone—Anorexia—Docetaxel—pancreatic cancer	0.000209	0.0013	CcSEcCtD
Mifepristone—Haemorrhage—Epirubicin—pancreatic cancer	0.000208	0.00129	CcSEcCtD
Mifepristone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000208	0.00129	CcSEcCtD
Mifepristone—Oedema peripheral—Epirubicin—pancreatic cancer	0.000205	0.00127	CcSEcCtD
Mifepristone—Hypotension—Docetaxel—pancreatic cancer	0.000205	0.00127	CcSEcCtD
Mifepristone—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000205	0.00127	CcSEcCtD
Mifepristone—Vomiting—Irinotecan—pancreatic cancer	0.000202	0.00125	CcSEcCtD
Mifepristone—Sinusitis—Doxorubicin—pancreatic cancer	0.000201	0.00125	CcSEcCtD
Mifepristone—Dizziness—Fluorouracil—pancreatic cancer	0.000201	0.00125	CcSEcCtD
Mifepristone—Rash—Irinotecan—pancreatic cancer	0.0002	0.00124	CcSEcCtD
Mifepristone—Dermatitis—Irinotecan—pancreatic cancer	0.0002	0.00124	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.0002	0.00124	CcSEcCtD
Mifepristone—Headache—Irinotecan—pancreatic cancer	0.000199	0.00123	CcSEcCtD
Mifepristone—Insomnia—Docetaxel—pancreatic cancer	0.000198	0.00123	CcSEcCtD
Mifepristone—Vomiting—Gemcitabine—pancreatic cancer	0.000196	0.00122	CcSEcCtD
Mifepristone—Dyspnoea—Docetaxel—pancreatic cancer	0.000195	0.00121	CcSEcCtD
Mifepristone—Somnolence—Docetaxel—pancreatic cancer	0.000195	0.00121	CcSEcCtD
Mifepristone—Rash—Gemcitabine—pancreatic cancer	0.000195	0.00121	CcSEcCtD
Mifepristone—Dermatitis—Gemcitabine—pancreatic cancer	0.000195	0.00121	CcSEcCtD
Mifepristone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000194	0.0012	CcSEcCtD
Mifepristone—Headache—Gemcitabine—pancreatic cancer	0.000194	0.0012	CcSEcCtD
Mifepristone—Vomiting—Fluorouracil—pancreatic cancer	0.000193	0.0012	CcSEcCtD
Mifepristone—Haemorrhage—Doxorubicin—pancreatic cancer	0.000193	0.00119	CcSEcCtD
Mifepristone—Rash—Fluorouracil—pancreatic cancer	0.000192	0.00119	CcSEcCtD
Mifepristone—Dermatitis—Fluorouracil—pancreatic cancer	0.000191	0.00119	CcSEcCtD
Mifepristone—Decreased appetite—Docetaxel—pancreatic cancer	0.000191	0.00118	CcSEcCtD
Mifepristone—Headache—Fluorouracil—pancreatic cancer	0.00019	0.00118	CcSEcCtD
Mifepristone—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00019	0.00118	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000189	0.00117	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000189	0.00117	CcSEcCtD
Mifepristone—Fatigue—Docetaxel—pancreatic cancer	0.000189	0.00117	CcSEcCtD
Mifepristone—Angiopathy—Epirubicin—pancreatic cancer	0.000189	0.00117	CcSEcCtD
Mifepristone—Nausea—Irinotecan—pancreatic cancer	0.000188	0.00117	CcSEcCtD
Mifepristone—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000188	0.00116	CcSEcCtD
Mifepristone—Pain—Docetaxel—pancreatic cancer	0.000187	0.00116	CcSEcCtD
Mifepristone—Constipation—Docetaxel—pancreatic cancer	0.000187	0.00116	CcSEcCtD
Mifepristone—Chills—Epirubicin—pancreatic cancer	0.000187	0.00116	CcSEcCtD
Mifepristone—Nausea—Gemcitabine—pancreatic cancer	0.000184	0.00114	CcSEcCtD
Mifepristone—Mental disorder—Epirubicin—pancreatic cancer	0.000182	0.00113	CcSEcCtD
Mifepristone—Malnutrition—Epirubicin—pancreatic cancer	0.000181	0.00112	CcSEcCtD
Mifepristone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000181	0.00112	CcSEcCtD
Mifepristone—Nausea—Fluorouracil—pancreatic cancer	0.00018	0.00112	CcSEcCtD
Mifepristone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000179	0.00111	CcSEcCtD
Mifepristone—Back pain—Epirubicin—pancreatic cancer	0.000175	0.00109	CcSEcCtD
Mifepristone—Angiopathy—Doxorubicin—pancreatic cancer	0.000175	0.00108	CcSEcCtD
Mifepristone—Muscle spasms—Epirubicin—pancreatic cancer	0.000174	0.00108	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000174	0.00108	CcSEcCtD
Mifepristone—Abdominal pain—Docetaxel—pancreatic cancer	0.000173	0.00107	CcSEcCtD
Mifepristone—Body temperature increased—Docetaxel—pancreatic cancer	0.000173	0.00107	CcSEcCtD
Mifepristone—Chills—Doxorubicin—pancreatic cancer	0.000173	0.00107	CcSEcCtD
Mifepristone—Mental disorder—Doxorubicin—pancreatic cancer	0.000169	0.00105	CcSEcCtD
Mifepristone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000168	0.00104	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—pancreatic cancer	0.000168	0.00104	CcSEcCtD
Mifepristone—Malaise—Epirubicin—pancreatic cancer	0.000163	0.00101	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—pancreatic cancer	0.000162	0.00101	CcSEcCtD
Mifepristone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000162	0.001	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—pancreatic cancer	0.000161	0.000999	CcSEcCtD
Mifepristone—Asthenia—Docetaxel—pancreatic cancer	0.000157	0.000975	CcSEcCtD
Mifepristone—Hypertension—Epirubicin—pancreatic cancer	0.000156	0.00097	CcSEcCtD
Mifepristone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000156	0.000964	CcSEcCtD
Mifepristone—Pruritus—Docetaxel—pancreatic cancer	0.000155	0.000962	CcSEcCtD
Mifepristone—Myalgia—Epirubicin—pancreatic cancer	0.000154	0.000956	CcSEcCtD
Mifepristone—Arthralgia—Epirubicin—pancreatic cancer	0.000154	0.000956	CcSEcCtD
Mifepristone—Anxiety—Epirubicin—pancreatic cancer	0.000154	0.000953	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000153	0.00095	CcSEcCtD
Mifepristone—Discomfort—Epirubicin—pancreatic cancer	0.000152	0.000945	CcSEcCtD
Mifepristone—Malaise—Doxorubicin—pancreatic cancer	0.000151	0.000937	CcSEcCtD
Mifepristone—Dry mouth—Epirubicin—pancreatic cancer	0.000151	0.000935	CcSEcCtD
Mifepristone—Diarrhoea—Docetaxel—pancreatic cancer	0.00015	0.00093	CcSEcCtD
Mifepristone—Oedema—Epirubicin—pancreatic cancer	0.000148	0.000917	CcSEcCtD
Mifepristone—Infection—Epirubicin—pancreatic cancer	0.000147	0.000911	CcSEcCtD
Mifepristone—Nervous system disorder—Epirubicin—pancreatic cancer	0.000145	0.000899	CcSEcCtD
Mifepristone—Dizziness—Docetaxel—pancreatic cancer	0.000145	0.000899	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—pancreatic cancer	0.000145	0.000897	CcSEcCtD
Mifepristone—Skin disorder—Epirubicin—pancreatic cancer	0.000144	0.000891	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—pancreatic cancer	0.000143	0.000885	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—pancreatic cancer	0.000143	0.000885	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—pancreatic cancer	0.000142	0.000882	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000142	0.000879	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—pancreatic cancer	0.000141	0.000874	CcSEcCtD
Mifepristone—Anorexia—Epirubicin—pancreatic cancer	0.000141	0.000874	CcSEcCtD
Mifepristone—Dry mouth—Doxorubicin—pancreatic cancer	0.00014	0.000865	CcSEcCtD
Mifepristone—Vomiting—Docetaxel—pancreatic cancer	0.000139	0.000864	CcSEcCtD
Mifepristone—Rash—Docetaxel—pancreatic cancer	0.000138	0.000857	CcSEcCtD
Mifepristone—Hypotension—Epirubicin—pancreatic cancer	0.000138	0.000857	CcSEcCtD
Mifepristone—Dermatitis—Docetaxel—pancreatic cancer	0.000138	0.000856	CcSEcCtD
Mifepristone—Headache—Docetaxel—pancreatic cancer	0.000137	0.000852	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—pancreatic cancer	0.000137	0.000848	CcSEcCtD
Mifepristone—Infection—Doxorubicin—pancreatic cancer	0.000136	0.000843	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000135	0.000835	CcSEcCtD
Mifepristone—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000134	0.000832	CcSEcCtD
Mifepristone—Insomnia—Epirubicin—pancreatic cancer	0.000134	0.000829	CcSEcCtD
Mifepristone—Skin disorder—Doxorubicin—pancreatic cancer	0.000133	0.000824	CcSEcCtD
Mifepristone—Dyspnoea—Epirubicin—pancreatic cancer	0.000132	0.000817	CcSEcCtD
Mifepristone—Somnolence—Epirubicin—pancreatic cancer	0.000131	0.000815	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—pancreatic cancer	0.00013	0.000809	CcSEcCtD
Mifepristone—Nausea—Docetaxel—pancreatic cancer	0.00013	0.000807	CcSEcCtD
Mifepristone—Decreased appetite—Epirubicin—pancreatic cancer	0.000129	0.000797	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—pancreatic cancer	0.000128	0.000793	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000128	0.000792	CcSEcCtD
Mifepristone—Fatigue—Epirubicin—pancreatic cancer	0.000127	0.00079	CcSEcCtD
Mifepristone—Pain—Epirubicin—pancreatic cancer	0.000126	0.000784	CcSEcCtD
Mifepristone—Constipation—Epirubicin—pancreatic cancer	0.000126	0.000784	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000125	0.000773	CcSEcCtD
Mifepristone—Insomnia—Doxorubicin—pancreatic cancer	0.000124	0.000767	CcSEcCtD
Mifepristone—Dyspnoea—Doxorubicin—pancreatic cancer	0.000122	0.000756	CcSEcCtD
Mifepristone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000122	0.000756	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—pancreatic cancer	0.000122	0.000754	CcSEcCtD
Mifepristone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000121	0.00075	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—pancreatic cancer	0.000119	0.000737	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000118	0.000732	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—pancreatic cancer	0.000118	0.000731	CcSEcCtD
Mifepristone—Urticaria—Epirubicin—pancreatic cancer	0.000117	0.000728	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—pancreatic cancer	0.000117	0.000725	CcSEcCtD
Mifepristone—Pain—Doxorubicin—pancreatic cancer	0.000117	0.000725	CcSEcCtD
Mifepristone—Abdominal pain—Epirubicin—pancreatic cancer	0.000117	0.000725	CcSEcCtD
Mifepristone—Body temperature increased—Epirubicin—pancreatic cancer	0.000117	0.000725	CcSEcCtD
Mifepristone—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000113	0.000699	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000112	0.000694	CcSEcCtD
Mifepristone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000109	0.000675	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—pancreatic cancer	0.000109	0.000674	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—pancreatic cancer	0.000108	0.000671	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—pancreatic cancer	0.000108	0.000671	CcSEcCtD
Mifepristone—Asthenia—Epirubicin—pancreatic cancer	0.000106	0.000658	CcSEcCtD
Mifepristone—Pruritus—Epirubicin—pancreatic cancer	0.000105	0.000649	CcSEcCtD
Mifepristone—Diarrhoea—Epirubicin—pancreatic cancer	0.000101	0.000627	CcSEcCtD
Mifepristone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000101	0.000625	CcSEcCtD
Mifepristone—Asthenia—Doxorubicin—pancreatic cancer	9.82e-05	0.000609	CcSEcCtD
Mifepristone—Dizziness—Epirubicin—pancreatic cancer	9.78e-05	0.000606	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—pancreatic cancer	9.68e-05	0.0006	CcSEcCtD
Mifepristone—Vomiting—Epirubicin—pancreatic cancer	9.4e-05	0.000583	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—pancreatic cancer	9.36e-05	0.00058	CcSEcCtD
Mifepristone—Rash—Epirubicin—pancreatic cancer	9.32e-05	0.000578	CcSEcCtD
Mifepristone—Dermatitis—Epirubicin—pancreatic cancer	9.32e-05	0.000578	CcSEcCtD
Mifepristone—Headache—Epirubicin—pancreatic cancer	9.26e-05	0.000574	CcSEcCtD
Mifepristone—Dizziness—Doxorubicin—pancreatic cancer	9.05e-05	0.000561	CcSEcCtD
Mifepristone—Nausea—Epirubicin—pancreatic cancer	8.78e-05	0.000545	CcSEcCtD
Mifepristone—Vomiting—Doxorubicin—pancreatic cancer	8.7e-05	0.000539	CcSEcCtD
Mifepristone—Rash—Doxorubicin—pancreatic cancer	8.63e-05	0.000535	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—pancreatic cancer	8.62e-05	0.000534	CcSEcCtD
Mifepristone—Headache—Doxorubicin—pancreatic cancer	8.57e-05	0.000531	CcSEcCtD
Mifepristone—Nausea—Doxorubicin—pancreatic cancer	8.13e-05	0.000504	CcSEcCtD
Mifepristone—CYP3A7—Metabolism—ARG2—pancreatic cancer	3.66e-05	0.000757	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—JAG2—pancreatic cancer	3.61e-05	0.000747	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	3.56e-05	0.000738	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MEN1—pancreatic cancer	3.56e-05	0.000737	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	3.51e-05	0.000727	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	3.49e-05	0.000722	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	3.46e-05	0.000716	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.45e-05	0.000714	CbGpPWpGaD
Mifepristone—AR—Gene Expression—EZH2—pancreatic cancer	3.43e-05	0.000711	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SHH—pancreatic cancer	3.39e-05	0.000703	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH4—pancreatic cancer	3.37e-05	0.000698	CbGpPWpGaD
Mifepristone—ABCC1—Disease—JAG2—pancreatic cancer	3.36e-05	0.000697	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NOTCH3—pancreatic cancer	3.36e-05	0.000696	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IAPP—pancreatic cancer	3.35e-05	0.000694	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—SMAD4—pancreatic cancer	3.32e-05	0.000688	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MEN1—pancreatic cancer	3.32e-05	0.000687	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SLC2A2—pancreatic cancer	3.29e-05	0.000682	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TNF—pancreatic cancer	3.23e-05	0.000669	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTCH1—pancreatic cancer	3.22e-05	0.000666	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTHLH—pancreatic cancer	3.22e-05	0.000666	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.21e-05	0.000665	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TYMP—pancreatic cancer	3.2e-05	0.000662	CbGpPWpGaD
Mifepristone—AR—Gene Expression—HSPA1A—pancreatic cancer	3.18e-05	0.000659	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SHH—pancreatic cancer	3.16e-05	0.000655	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MEN1—pancreatic cancer	3.16e-05	0.000655	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IAPP—pancreatic cancer	3.12e-05	0.000647	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.07e-05	0.000636	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PRSS1—pancreatic cancer	3.05e-05	0.000631	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.02e-05	0.000626	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HSPA1B—pancreatic cancer	3e-05	0.000621	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	3e-05	0.000621	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GLP1R—pancreatic cancer	2.95e-05	0.000612	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SST—pancreatic cancer	2.94e-05	0.000609	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	2.94e-05	0.000609	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.91e-05	0.000603	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—DPYD—pancreatic cancer	2.91e-05	0.000602	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—JAG1—pancreatic cancer	2.88e-05	0.000596	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH3—pancreatic cancer	2.87e-05	0.000594	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	2.86e-05	0.000592	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.8e-05	0.00058	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.78e-05	0.000575	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	2.77e-05	0.000574	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SLC2A2—pancreatic cancer	2.76e-05	0.000571	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MYC—pancreatic cancer	2.74e-05	0.000567	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.73e-05	0.000565	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CNR1—pancreatic cancer	2.71e-05	0.000562	CbGpPWpGaD
Mifepristone—ABCC1—Disease—JAG1—pancreatic cancer	2.68e-05	0.000556	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ARG2—pancreatic cancer	2.64e-05	0.000547	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.63e-05	0.000545	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GCG—pancreatic cancer	2.62e-05	0.000543	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—EZH2—pancreatic cancer	2.6e-05	0.000539	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GLP1R—pancreatic cancer	2.58e-05	0.000533	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD44—pancreatic cancer	2.55e-05	0.000528	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	2.55e-05	0.000528	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—DPYD—pancreatic cancer	2.53e-05	0.000525	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HSPA1A—pancreatic cancer	2.53e-05	0.000524	CbGpPWpGaD
Mifepristone—AR—Gene Expression—SMAD4—pancreatic cancer	2.53e-05	0.000524	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AGTR1—pancreatic cancer	2.5e-05	0.000518	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STK11—pancreatic cancer	2.47e-05	0.000511	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NOTCH1—pancreatic cancer	2.45e-05	0.000507	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	2.41e-05	0.0005	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC2A2—pancreatic cancer	2.4e-05	0.000498	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.4e-05	0.000497	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.36e-05	0.000489	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—PPARG—pancreatic cancer	2.31e-05	0.000479	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TYMP—pancreatic cancer	2.31e-05	0.000478	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.3e-05	0.000476	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.19e-05	0.000454	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PRSS1—pancreatic cancer	2.17e-05	0.000449	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SMAD4—pancreatic cancer	2.16e-05	0.000447	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CD44—pancreatic cancer	2.13e-05	0.000442	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.13e-05	0.000442	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.11e-05	0.000437	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HES1—pancreatic cancer	2.11e-05	0.000437	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.09e-05	0.000433	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—pancreatic cancer	2.08e-05	0.000432	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.07e-05	0.000429	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.06e-05	0.000426	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GCG—pancreatic cancer	2.05e-05	0.000424	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SMAD4—pancreatic cancer	2.01e-05	0.000417	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ARG2—pancreatic cancer	1.99e-05	0.000413	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HES1—pancreatic cancer	1.97e-05	0.000407	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—STK11—pancreatic cancer	1.92e-05	0.000399	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SMAD4—pancreatic cancer	1.92e-05	0.000398	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.91e-05	0.000395	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.88e-05	0.000389	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NOTCH1—pancreatic cancer	1.87e-05	0.000386	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CD44—pancreatic cancer	1.86e-05	0.000386	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GLP1R—pancreatic cancer	1.86e-05	0.000386	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.86e-05	0.000385	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TERT—pancreatic cancer	1.85e-05	0.000383	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—DPYD—pancreatic cancer	1.83e-05	0.000379	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.81e-05	0.000374	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GCG—pancreatic cancer	1.79e-05	0.00037	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HIF1A—pancreatic cancer	1.77e-05	0.000366	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TSC2—pancreatic cancer	1.76e-05	0.000365	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PPARG—pancreatic cancer	1.76e-05	0.000365	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TYMP—pancreatic cancer	1.74e-05	0.000361	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	1.74e-05	0.00036	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APOE—pancreatic cancer	1.72e-05	0.000357	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TERT—pancreatic cancer	1.72e-05	0.000357	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.71e-05	0.000354	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.71e-05	0.000353	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KDR—pancreatic cancer	1.69e-05	0.00035	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—STK11—pancreatic cancer	1.68e-05	0.000348	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.67e-05	0.000346	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TYMS—pancreatic cancer	1.66e-05	0.000343	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HIF1A—pancreatic cancer	1.65e-05	0.000341	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TSC2—pancreatic cancer	1.64e-05	0.00034	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.64e-05	0.00034	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APOE—pancreatic cancer	1.61e-05	0.000333	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NFKBIA—pancreatic cancer	1.61e-05	0.000333	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.59e-05	0.00033	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH1—pancreatic cancer	1.59e-05	0.00033	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	1.58e-05	0.000328	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.58e-05	0.000327	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CG—pancreatic cancer	1.56e-05	0.000322	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGF—pancreatic cancer	1.54e-05	0.000319	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOTCH1—pancreatic cancer	1.48e-05	0.000307	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.45e-05	0.000301	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TYMS—pancreatic cancer	1.44e-05	0.000299	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGF—pancreatic cancer	1.43e-05	0.000297	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.42e-05	0.000293	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	1.41e-05	0.000293	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.4e-05	0.000291	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.4e-05	0.000291	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—DPYD—pancreatic cancer	1.38e-05	0.000286	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CD—pancreatic cancer	1.37e-05	0.000283	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—APOE—pancreatic cancer	1.35e-05	0.000279	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CD44—pancreatic cancer	1.35e-05	0.000279	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPARG—pancreatic cancer	1.34e-05	0.000277	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.32e-05	0.000274	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—pancreatic cancer	1.32e-05	0.000273	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.31e-05	0.000272	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.3e-05	0.00027	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GCG—pancreatic cancer	1.29e-05	0.000267	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CD—pancreatic cancer	1.28e-05	0.000264	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.27e-05	0.000264	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.24e-05	0.000256	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.23e-05	0.000254	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CG—pancreatic cancer	1.22e-05	0.000252	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—STK11—pancreatic cancer	1.21e-05	0.000251	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CB—pancreatic cancer	1.19e-05	0.000247	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.19e-05	0.000246	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—APOE—pancreatic cancer	1.17e-05	0.000243	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPARG—pancreatic cancer	1.17e-05	0.000243	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL8—pancreatic cancer	1.15e-05	0.000237	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CB—pancreatic cancer	1.11e-05	0.00023	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—pancreatic cancer	1.1e-05	0.000228	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CASP3—pancreatic cancer	1.1e-05	0.000227	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.07e-05	0.000222	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CD—pancreatic cancer	1.07e-05	0.000221	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—pancreatic cancer	1.07e-05	0.000221	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	1.06e-05	0.000219	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CTNNB1—pancreatic cancer	1.06e-05	0.000219	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.04e-05	0.000216	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—pancreatic cancer	1.04e-05	0.000215	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—pancreatic cancer	1.03e-05	0.000213	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARG—pancreatic cancer	1.02e-05	0.000212	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CD44—pancreatic cancer	1.02e-05	0.00021	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—pancreatic cancer	1e-05	0.000208	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CTNNB1—pancreatic cancer	9.86e-06	0.000204	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GCG—pancreatic cancer	9.74e-06	0.000202	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—pancreatic cancer	9.61e-06	0.000199	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CD44—pancreatic cancer	9.57e-06	0.000198	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SRC—pancreatic cancer	9.56e-06	0.000198	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	9.32e-06	0.000193	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CB—pancreatic cancer	9.31e-06	0.000193	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—pancreatic cancer	9.31e-06	0.000193	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—pancreatic cancer	9.22e-06	0.000191	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—pancreatic cancer	9.22e-06	0.000191	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NRAS—pancreatic cancer	9.19e-06	0.00019	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GCG—pancreatic cancer	9.18e-06	0.00019	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—STK11—pancreatic cancer	9.16e-06	0.00019	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—pancreatic cancer	9.13e-06	0.000189	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SRC—pancreatic cancer	8.91e-06	0.000184	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	8.66e-06	0.000179	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—STK11—pancreatic cancer	8.63e-06	0.000179	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—pancreatic cancer	8.59e-06	0.000178	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NRAS—pancreatic cancer	8.57e-06	0.000177	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—pancreatic cancer	8.56e-06	0.000177	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFB1—pancreatic cancer	8.54e-06	0.000177	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—DPYD—pancreatic cancer	8.51e-06	0.000176	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOE—pancreatic cancer	8.49e-06	0.000176	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—pancreatic cancer	8.38e-06	0.000173	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	8.12e-06	0.000168	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	8.08e-06	0.000167	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—pancreatic cancer	8.05e-06	0.000167	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—pancreatic cancer	8.04e-06	0.000167	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—pancreatic cancer	7.98e-06	0.000165	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFB1—pancreatic cancer	7.96e-06	0.000165	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—pancreatic cancer	7.91e-06	0.000164	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TYMS—pancreatic cancer	7.88e-06	0.000163	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—pancreatic cancer	7.81e-06	0.000162	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	7.66e-06	0.000159	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—pancreatic cancer	7.61e-06	0.000158	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TYMS—pancreatic cancer	7.42e-06	0.000154	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARG—pancreatic cancer	7.39e-06	0.000153	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—pancreatic cancer	7.38e-06	0.000153	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—pancreatic cancer	7.27e-06	0.000151	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—pancreatic cancer	7.03e-06	0.000146	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—pancreatic cancer	7.02e-06	0.000145	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—pancreatic cancer	6.96e-06	0.000144	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—pancreatic cancer	6.78e-06	0.00014	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	6.73e-06	0.000139	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—pancreatic cancer	6.73e-06	0.000139	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOE—pancreatic cancer	6.4e-06	0.000133	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—pancreatic cancer	6.27e-06	0.00013	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CD44—pancreatic cancer	6.26e-06	0.00013	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOE—pancreatic cancer	6.04e-06	0.000125	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GCG—pancreatic cancer	6e-06	0.000124	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—pancreatic cancer	5.94e-06	0.000123	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	5.87e-06	0.000122	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—pancreatic cancer	5.82e-06	0.00012	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CG—pancreatic cancer	5.78e-06	0.00012	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—pancreatic cancer	5.68e-06	0.000118	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—STK11—pancreatic cancer	5.64e-06	0.000117	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARG—pancreatic cancer	5.58e-06	0.000116	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—pancreatic cancer	5.54e-06	0.000115	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	5.45e-06	0.000113	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—pancreatic cancer	5.28e-06	0.000109	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARG—pancreatic cancer	5.26e-06	0.000109	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CD—pancreatic cancer	5.08e-06	0.000105	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—pancreatic cancer	5.07e-06	0.000105	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	4.95e-06	0.000103	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TYMS—pancreatic cancer	4.85e-06	0.0001	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	4.79e-06	9.92e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—pancreatic cancer	4.64e-06	9.6e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CB—pancreatic cancer	4.43e-06	9.17e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.39e-06	9.09e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.17e-06	8.64e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.14e-06	8.56e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—pancreatic cancer	4.04e-06	8.37e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOE—pancreatic cancer	3.95e-06	8.17e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—pancreatic cancer	3.83e-06	7.93e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.61e-06	7.47e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	3.58e-06	7.41e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.56e-06	7.38e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.44e-06	7.12e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.13e-06	6.48e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—pancreatic cancer	2.92e-06	6.05e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.73e-06	5.65e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.7e-06	5.6e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.7e-06	5.59e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.54e-06	5.27e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.36e-06	4.88e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—pancreatic cancer	2.21e-06	4.57e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.08e-06	4.3e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.66e-06	3.45e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.36e-06	2.81e-05	CbGpPWpGaD
